LEANNE MURRAY: Open Payments
NPI 1689195463 · BAY SAINT LOUIS, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$536 in 22 payments from 12 companies in 2025. Trend: 2023 $789 · 2024 $349 · 2025 $536
Food & beverage: $536
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $136 |
| Astellas Pharma US Inc | 4 | $90 |
| Sage Therapeutics, LLC | 2 | $52 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $52 |
| ABBVIE INC. | 3 | $51 |
| Sumitomo Pharma America, Inc. | 2 | $31 |
| Supernus Pharmaceuticals, Inc. | 1 | $25 |
| MILLICENT US INC | 1 | $24 |
| Abbott Laboratories | 1 | $21 |
| Exeltis, USA Inc. | 1 | $20 |
Products named: AIRSUPRA, Veozah, ZURZUVAE, VRAYLAR, MYFEMBREE, Qelbree, FEMRING, FREESTYLE LIBRE 3.
Industry payments across MS — which companies pay providers there.
